Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

EDX Medical builds momentum around precision cancer testing

EDX Medical is advancing precision cancer diagnostics through large-scale prostate testing in Scotland, AIM market access and a wider commercial rollout of disease detection products...

July 7, 2026

Cizzle Bio sharpens focus on earlier lung cancer detection

Cizzle Bio is advancing a minimally invasive blood test aimed at helping lung cancer be detected earlier...

July 7, 2026

Turning scientific breakthroughs into investable commercial opportunities

Scientific breakthroughs become commercially relevant when strong research is matched with scalable infrastructure, business discipline and a clear route to adoption...

July 7, 2026

Why biotech cycles can open timely growth opportunities

Biotech cycles can create attractive opportunities when lower valuations meet advancing science, upcoming clinical milestones, and strong strategic demand from large pharmaceutical companies...

July 3, 2026

Verici Dx gains nationwide access for kidney transplant test

Verici Dx has secured New York State approval for Tutivia, giving the kidney transplant rejection risk test nationwide US access...

July 2, 2026

Genflow Biosciences prepares for key longevity data

Genflow Biosciences is set to present full dog longevity study results that could shape its animal health strategy and partnership prospects...

June 29, 2026

Biotech Growth Trust Plc – Annual Report Snapshot 2026

Visit Biotech Growth Trust Plc’s 2026 Annual Report page to review returns, financial highlights, portfolio commentary, KPIs, historic performance and Chair’s statement...

June 29, 2026

AstraZeneca and Daiichi Sankyo’s Datroway recommended for EU approval in metastatic TNBC

Astrazeneca Plc says CHMP has recommended Datroway for EU approval as first-line treatment in metastatic triple-negative breast cancer...

June 29, 2026

Verici Dx reports full-year growth in Tutivia revenues and FY25 final results

Verici Dx reported higher annual revenues, first Tutivia sales and continued commercial progress, alongside a post-period equity fundraise...

June 29, 2026

Ethtry reports strengthened balance sheet in 2025 results

Ethtry reported a 2025 loss of £619,270, while cash increased to £4.3 million following a £5.3 million fundraising, supporting its renewable energy strategy and post-year-end Ethereum treasury rollout...

June 26, 2026

Praxis Precision Medicines wins FDA Breakthrough Status for rare epilepsy treatment

Praxis Precision Medicines has received FDA Breakthrough Therapy Designation for elsunersen, adding momentum to a rare epilepsy programme held in Biotech Growth Trust’s portfolio...

June 25, 2026

Cizzle Bio targets earlier detection in gastric cancer

Cizzle Bio is targeting the gastric cancer diagnostic gap with DEX-G2, a blood test designed to support earlier detection where routine screening is limited...

June 25, 2026

Spire Healthcare Group Plc Spire Healthcare receives further extension to PUSU deadline

Spire Healthcare says discussions with Toscafund continue, with the Takeover Panel consenting to a further extension of the offer deadline...

June 25, 2026

Verici Dx secures New York State laboratory certification for Tutivia test

Verici Dx has obtained New York State clinical laboratory certification, completing authorisation for Tutivia across all 50 US states and the District of Columbia...

June 24, 2026

Dr Allan Syms on Cizzle Biotechnology’s CIZ1B US accreditation

Cizzle Biotechnology Executive Chairman Dr Allan Syms discusses the CIZ1B early lung cancer test gaining CLIA accreditation in the US, marking a shift towards commercial adoption, royalty revenues, and wider..

June 22, 2026

Healthspan becomes a clearer investment theme in preventive wellness

Healthspan is becoming a stronger investment theme as consumers focus on daily habits that support healthier ageing...

June 22, 2026

Genflow Biosciences to Attend BIO San Diego as Chairman Gad Berdugo Joins mRNA Panel

Genflow Biosciences will attend BIO San Diego, with chairman Gad Berdugo joining an mRNA panel...

June 20, 2026

GSK gains US FDA approval for oral cUTI antibiotic Utebzi

GSK has secured US FDA approval for Utebzi, an oral carbapenem antibiotic for certain adult patients with complicated urinary tract infections...

June 18, 2026

Cizzle Biotechnology US Launch Opens the Door to Lung Cancer Test Royalties (video)

Cizzle Biotechnology has reached a pivotal commercial milestone, with its CIZ1B lung cancer blood test now available for clinical use in the United States. Executive Chairman Dr Allan Syms discusses..

June 17, 2026

Syncona appoints Norman Crighton to the Board

Syncona has appointed Norman Crighton as a non-executive director, with committee roles and shareholder priorities outlined...

June 17, 2026

News and Interview Alerts

Company Presentations

Time Finance Profits Surge, Book Grows 86% as New Strategy Targets £300m Lending

Challenger Energy plc Transforming Exploration Potential into a Frontier Opportunity

Cerillion PLC Annual Results 2024 ‘Record Highs’, Louis Hall CEO

Q&As

Oriole Resources’s CFO outlines next steps at Mbe, Senala, and Bibemi (LON:ORR)

13 July 2026

Sintana Energy fully funded for multi-country drilling programme

9 July 2026

Thor Energy CEO Andrew Hume discusses HY-Range hydrogen results and seismic plans

9 July 2026

Time Finance CEO Ed Rimmer discusses record profit and lending book growth

8 July 2026

PowerPlay Media outlines AIM plans and sports media growth strategy

8 July 2026

Hardman & Co

Arbuthnot Banking Group Plc 1H’26: accelerating franchise growth

4 August 2026

Real Estate Credit Investments maintains dividend as credit remains resilient

3 August 2026

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

13 July 2026

Cavendish plc: Solid performance in still tough markets

30 June 2026

Cavendish plc delivers solid performance in tough markets

24 June 2026

Green News

Quadrise extends Morocco representation agreement

31 July 2026

Ferro-Alloy Resources appoints new CEO and advances US funding plans

31 July 2026

Quadrise and Licella advance low-carbon marine fuel testing

30 July 2026

Drax delivers solid first-half performance and advances growth plans

30 July 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Oriole Resources Senala JV Unlocks Funded Drilling as Mbe Builds Scale in Cameroon (video)

Sintana Energy: A Fully Funded 10-Well Runway With Mopane Already Anchoring the Story (video)

Thor Energy PLC: Hydrogen Readings Jump 10x as HY-Range Moves Toward Drill Targets (video)

Time Finance: Record Profits, Bigger Margins and £80m of Firepower for the Next Lending Push (video)

PowerPlay Media Targets AIM With $12m Revenue Ambition And Global Sports Rights Momentum (video)

ICG Enterprise Trust PLC: Mark Thomas Sees Exit Momentum Building As Defensive Growth Starts To Bite (video)

BrokerTalk

Sintana Energy’s Atlantic Margin activity pipeline remains firmly in focus, says Cavendish

7 July 2026

Verici Dx FY25 results in line as Tutivia outlook strengthens, says Singer Capital Markets

6 July 2026

Ilika Plc capital raise supports Stereax launch and Goliath progress, says Cavendish

6 July 2026

CMC Markets upgraded to Buy as FY2027 outlook steps higher, Panmure Liberum

1 July 2026

Cavendish plc: Solid performance in still tough markets

30 June 2026

Funds

JEDT European investment fund buoyed by financial sector strength

4 August 2026

Fidelity Emerging Markets outperforms as technology exposure rises highlighted in latest research (LON:FEML)

30 July 2026

Geiger Counter posts strong one-year growth as uranium outlook strengthens

30 July 2026

Biotech Growth Trust notes $2.2 billion acquisition of Forte Biosciences

28 July 2026

Ruffer Investment Company delivers positive 2026 returns

24 July 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Smith & Nephew maintains profit guidance as H1 trading margin improves

4 August 2026

Antofagasta to host Q&A video conference alongside 2026 half-year results

3 August 2026

Pearson reports 4% revenue growth and 14% profit increase in H1 2026

31 July 2026

NatWest Group reports £3.0bn H1 profit and raises 2026 guidance

31 July 2026

UK Broker Ratings

Sirius Real Estate (SRE.L): Investor Outlook Reveals 23.81% Potential Upside Amid Strong Buy Ratings

6 August 2026

Edinburgh Investment Trust PLC (EDIN.L) Stock Analysis: Navigating a Steady Course with Strong Buy Sentiment

6 August 2026

SSP Group PLC (SSPG.L): Investor Insights and Growth Potential Amid a 10.45% Upside

6 August 2026

Syncona Limited (SYNC.L): Analyst Consensus Signals a Striking 90.57% Upside Potential

6 August 2026

Supermarket Income REIT (SUPR.L) Stock Analysis: A High-Yield Opportunity in the Retail Real Estate Sector

6 August 2026

Health

EDX Medical builds momentum around precision cancer testing

EDX Medical is advancing precision cancer diagnostics through large-scale prostate testing in Scotland, AIM market access and a wider commercial rollout of disease detection products...

July 7, 2026

Cizzle Bio sharpens focus on earlier lung cancer detection

Cizzle Bio is advancing a minimally invasive blood test aimed at helping lung cancer be detected earlier...

July 7, 2026

Turning scientific breakthroughs into investable commercial opportunities

Scientific breakthroughs become commercially relevant when strong research is matched with scalable infrastructure, business discipline and a clear route to adoption...

July 7, 2026

Why biotech cycles can open timely growth opportunities

Biotech cycles can create attractive opportunities when lower valuations meet advancing science, upcoming clinical milestones, and strong strategic demand from large pharmaceutical companies...

July 3, 2026

Verici Dx gains nationwide access for kidney transplant test

Verici Dx has secured New York State approval for Tutivia, giving the kidney transplant rejection risk test nationwide US access...

July 2, 2026

Genflow Biosciences prepares for key longevity data

Genflow Biosciences is set to present full dog longevity study results that could shape its animal health strategy and partnership prospects...

June 29, 2026

Biotech Growth Trust Plc – Annual Report Snapshot 2026

Visit Biotech Growth Trust Plc’s 2026 Annual Report page to review returns, financial highlights, portfolio commentary, KPIs, historic performance and Chair’s statement...

June 29, 2026

AstraZeneca and Daiichi Sankyo’s Datroway recommended for EU approval in metastatic TNBC

Astrazeneca Plc says CHMP has recommended Datroway for EU approval as first-line treatment in metastatic triple-negative breast cancer...

June 29, 2026

Verici Dx reports full-year growth in Tutivia revenues and FY25 final results

Verici Dx reported higher annual revenues, first Tutivia sales and continued commercial progress, alongside a post-period equity fundraise...

June 29, 2026

Ethtry reports strengthened balance sheet in 2025 results

June 26, 2026

Praxis Precision Medicines wins FDA Breakthrough Status for rare epilepsy treatment

Praxis Precision Medicines has received FDA Breakthrough Therapy Designation for elsunersen, adding momentum to a rare epilepsy programme held in Biotech Growth Trust’s portfolio...

June 25, 2026

Cizzle Bio targets earlier detection in gastric cancer

Cizzle Bio is targeting the gastric cancer diagnostic gap with DEX-G2, a blood test designed to support earlier detection where routine screening is limited...

June 25, 2026

Spire Healthcare Group Plc Spire Healthcare receives further extension to PUSU deadline

Spire Healthcare says discussions with Toscafund continue, with the Takeover Panel consenting to a further extension of the offer deadline...

June 25, 2026

Verici Dx secures New York State laboratory certification for Tutivia test

Verici Dx has obtained New York State clinical laboratory certification, completing authorisation for Tutivia across all 50 US states and the District of Columbia...